Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(S)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinoline (S)-α-Hydroxybenzeneacetate is an intermediate used in the synthesis of (S)-Laudanosine (L178525), which is a metabolite of the neuromuscular-blocking drugs Atracurium (A794500) and Cisatracurium (C496700) with potentially toxic systemic effects. It crosses the blood-brain barrier and may cause excitement and seizure activity.